The Latest Cardiac and Vascular News
CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or are at high risk for hyperkalemia (HK), in Europe and the US CARE-HK in HF is designed to evaluate the use of Veltassa® in enabling patients to remain on RAASi therapy […]
Online Training Course Aims to Improve Outcomes for Sudden Cardiac Arrest Victims HERNON, Va., April 27, 2021 /PRNewswire/ — Connect For Education Inc. (C4E), a leading provider of online education technologies, is proud to announce a successful launch of Call.Push.Shock, a highly-interactive online training and education curriculum that provides users of all ages […]
– First-of-its-kind outcomes trial designed to assess cardiovascular risk reduction in patients with documented intolerance to statin therapy – – Nearly half of trial participants are women, a significantly higher proportion than have been included in any other previous cardiovascular outcomes study in history – – Event driven MACE (major […]
The new name reflects the company’s commitment to pediatric, critical care, and chronic heart failure patients EDEN PRAIRIE, Minn., April 27, 2021 (GLOBE NEWSWIRE) — Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – […]
SUZHOU, China, April 24, 2021 /PRNewswire/ — A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusOne®“) developed by Peijia Medical (Suzhou) Co., Ltd., located in Suzhou Industrial Park, Jiangsu Province, was officially approved for commercialization […]
Novel device designed to address the root cause of mitral regurgitation, avoiding the need for open-heart surgery Company seeks partner to conduct a pivotal study in pursuit of a heart failure indication Clinical data supporting CE Mark to be presented as a late-breaking oral presentation at the virtual AATS 101st […]
Second Biotherapeutic Partnership of 2021 SAN CARLOS, Calif., April 26, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], today announced that it has entered into an agreement with a leading Japanese biotechnology company related to BioCardia Helix catheter biotherapeutic delivery product candidates. Under the terms of the agreement, BioCardia will receive $500,000, […]
Case series demonstrates the advantages of transvenous active-fixation Tempo Lead over epicardial leads for minimally invasive cardiac surgery procedures MENLO PARK, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., the leader in innovative temporary cardiac pacing technology, today announced the company’s Tempo® Temporary Pacing Lead was featured in a patient case series presented at the […]
The National Institute for Health and Care Excellence (NICE) finds HeartFlow Analysis can save NHS England as much as £391 per patient The digital technology is reducing reliance on unnecessary invasive diagnostic procedures and is cutting hospital waiting times The announcement follows NHS England’s MedTech Funding mandate, which went into effect on 01 […]
VAZKEPA (icosapent ethyl) is the first and only authorized treatment for its cardiovascular risk reduction indication1,2,3 VAZKEPA authorization for Great Britain follows recent VAZKEPA authorization for European Union DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the Medicines and […]
